Ubs Group Ag Boston Scientific Corp Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $2.53 Million - $2.91 Million	34,700 Added 12.15%	320,212 $26.8 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $2.75 Million - $3.18 Million	40,912 Added 16.73%	285,512 $22 Million
Q1 2024 May 13, 2024	SELL	$57.6 - $68.62 $2.3 Million - $2.74 Million	-40,000 Reduced 14.05%	244,600 $16.8 Million
Q3 2023 Nov 09, 2023	BUY	$50.19 - $54.68 $4.7 Million - $5.12 Million	93,700 Added 49.08%	284,600 $15 Million
Q2 2023 Aug 11, 2023	BUY	$49.72 - $54.64 $7.5 Million - $8.25 Million	150,900 Added 377.25%	190,900 $10.3 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $9.92 Million - $11 Million	-220,100 Reduced 84.62%	40,000 $2 Million
Q4 2022 Feb 08, 2023	BUY	$39.56 - $47.22 $3.16 Million - $3.78 Million	80,000 Added 44.42%	260,100 $12 Million
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $1.96 Million - $5.87 Million	53,500 Added 42.26%	180,100 $6.98 Million
Q2 2022 Aug 10, 2022	SELL	$35.24 - $47.1 $2.46 Million - $3.29 Million	-69,900 Reduced 35.57%	126,600 $4.72 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $4.71 Million - $5.19 Million	115,100 Added 141.4%	196,500 $8.7 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $5.75 Million - $6.78 Million	-151,166 Reduced 65.0%	81,400 $3.46 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.9 Million - $2.11 Million	-46,042 Reduced 16.53%	232,566 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $186,341 - $213,679	4,830 Added 1.76%	278,608 $11.9 Million
Q1 2021 May 12, 2021	BUY	$35.27 - $39.67 $9.18 Million - $10.3 Million	260,308 Added 1932.5%	273,778 $10.6 Million
Q4 2020 Feb 11, 2021	SELL	$33.15 - $41.97 $413,712 - $523,785	-12,480 Reduced 48.09%	13,470 $484,000
Q3 2020 Nov 12, 2020	SELL	$34.44 - $42.23 $436,354 - $535,054	-12,670 Reduced 32.81%	25,950 $992,000
Q2 2020 Jul 31, 2020	SELL	$30.19 - $39.11 $159,403 - $206,500	-5,280 Reduced 12.03%	38,620 $1.36 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $30.3 Million - $36.3 Million	-801,100 Reduced 94.8%	43,900 $1.99 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $19 Million - $23.4 Million	599,500 Added 244.2%	845,000 $29.9 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $6.06 Million - $7.13 Million	184,700 Added 303.78%	245,500 $9.45 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $399,916 - $511,368	14,900 Added 32.46%	60,800 $1.99 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $2,479 - $2,980	-100 Reduced 0.22%	45,900 $1.14 Million
Q1 2017 Nov 14, 2017	BUY	N/A	46,000	46,000 $1.14 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

Vanguard Group Inc Valley Forge, PA

131M
Shares

$12 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

126M
Shares

$11.5 Billion
0.22% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$5.74 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

37.8M
Shares

$3.45 Billion
2.37% of portfolio
Wellington Management Group LLP Boston, MA

32.8M
Shares

$3 Billion
0.49% of portfolio

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $131B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account